Patients with ERCC3 mutations manifest NER-defective syndromes including xeroderma pigmentosum group B (OMIM 610651) and trichothiodystrophy 2 (OMIM 616390) and have a high increased risk for skin cancer [19, 20]. This evidence concerns the gene ERCC3 and skin cancer.